These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16159804)

  • 21. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets.
    Memon IA; Sawa Y; Fukushima N; Matsumiya G; Miyagawa S; Taketani S; Sakakida SK; Kondoh H; Aleshin AN; Shimizu T; Okano T; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1333-41. PubMed ID: 16256786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can erythropoietin improve skeletal myoblast engraftment in infarcted myocardium?
    Chanséaume S; Azarnoush K; Maurel A; Bellamy V; Peyrard S; Bruneval P; Hagège AA; Menasché P
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):293-7. PubMed ID: 17669846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?
    Pouzet B; Vilquin JT; Hagège AA; Scorsin M; Messas E; Fiszman M; Schwartz K; Menasché P
    Circulation; 2000 Nov; 102(19 Suppl 3):III210-5. PubMed ID: 11082389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy?
    Pouly J; Hagège AA; Vilquin JT; Bissery A; Rouche A; Bruneval P; Duboc D; Desnos M; Fiszman M; Fromes Y; Menasché P
    Circulation; 2004 Sep; 110(12):1626-31. PubMed ID: 15364802
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts.
    Uchinaka A; Kawaguchi N; Hamada Y; Mori S; Miyagawa S; Saito A; Sawa Y; Matsuura N
    Cardiovasc Res; 2013 Jul; 99(1):102-10. PubMed ID: 23615564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiogenic pretreatment to enhance myocardial function after cellular cardiomyoplasty with skeletal myoblasts.
    Retuerto MA; Beckmann JT; Carbray J; Patejunas G; Sarateanu S; Kane BJ; Smulevitz B; McPherson DD; Rosengart TK
    J Thorac Cardiovasc Surg; 2007 Feb; 133(2):478-484.e2. PubMed ID: 17258586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bcl-2 expression enhances myoblast sheet transplantation therapy for acute myocardial infarction.
    Kitabayashi K; Siltanen A; Pätilä T; Mahar MA; Tikkanen I; Koponen J; Ono M; Sawa Y; Kankuri E; Harjula A
    Cell Transplant; 2010; 19(5):573-88. PubMed ID: 20089207
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smooth muscle cell sheet transplantation preserve cardiac function and minimize cardiac remodeling in a rat myocardial infarction model.
    Harada S; Nakamura Y; Shiraya S; Fujiwara Y; Kishimoto Y; Onohara T; Otsuki Y; Kishimoto S; Yamamoto Y; Hisatome I; Nishimura M
    J Cardiothorac Surg; 2016 Aug; 11(1):131. PubMed ID: 27495170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell delivery: intramyocardial injections or epicardial deposition? A head-to-head comparison.
    Hamdi H; Furuta A; Bellamy V; Bel A; Puymirat E; Peyrard S; Agbulut O; Menasché P
    Ann Thorac Surg; 2009 Apr; 87(4):1196-203. PubMed ID: 19324150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of cytoprotective cytokines in cardiac ischemia/reperfusion injury.
    Anderson CD; Heydarkhan-Hagvall S; Schenke-Layland K; Yang JQ; Jordan MC; Kim JK; Brown DA; Zuk PA; Laks H; Roos KP; Maclellan WR; Beygui RE
    J Surg Res; 2008 Aug; 148(2):164-71. PubMed ID: 18067924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
    Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
    Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation.
    Sakakibara Y; Nishimura K; Tambara K; Yamamoto M; Lu F; Tabata Y; Komeda M
    J Thorac Cardiovasc Surg; 2002 Jul; 124(1):50-6. PubMed ID: 12091808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maximizing ventricular function with multimodal cell-based gene therapy.
    Yau TM; Kim C; Li G; Zhang Y; Weisel RD; Li RK
    Circulation; 2005 Aug; 112(9 Suppl):I123-8. PubMed ID: 16159803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neoangiogenesis after combined transplantation of skeletal myoblasts and angiopoietic progenitors leads to increased cell engraftment and lower apoptosis rates in ischemic heart failure.
    Bonaros N; Rauf R; Werner E; Schlechta B; Rohde E; Kocher A; Bonatti J; Laufer G
    Interact Cardiovasc Thorac Surg; 2008 Apr; 7(2):249-55. PubMed ID: 17925321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell transplantation: differential effects of myoblasts and mesenchymal stem cells.
    Guarita-Souza LC; Carvalho KA; Rebelatto C; Senegaglia A; Hansen P; Furuta M; Miyague N; Francisco JC; Olandoski M; Faria-Neto JR; Oliveira SA; Brofman PR
    Int J Cardiol; 2006 Aug; 111(3):423-9. PubMed ID: 16290098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sphingosine-1-phosphate and myoblast transplantation on rat acute myocardial infarction.
    Yu H; Chen PL; Zhao Y; Gu X; He W; Gong Z
    Genet Mol Res; 2015 Oct; 14(4):13843-51. PubMed ID: 26535699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor and granulocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
    Guo YH; He JG; Wu JL; Yang L; Zhang DS; Tan XY; Qi RD
    Cytotherapy; 2008; 10(8):857-67. PubMed ID: 18956268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeated implantation is a more effective cell delivery method in skeletal myoblast transplantation for rat myocardial infarction.
    Premaratne GU; Tambara K; Fujita M; Lin X; Kanemitsu N; Tomita S; Sakaguchi G; Nakajima H; Ikeda T; Komeda M
    Circ J; 2006 Sep; 70(9):1184-9. PubMed ID: 16936434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene transfection with human hepatocyte growth factor complementary DNA plasmids attenuates cardiac remodeling after acute myocardial infarction in goat hearts implanted with ventricular assist devices.
    Shirakawa Y; Sawa Y; Takewa Y; Tatsumi E; Kaneda Y; Taenaka Y; Matsuda H
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):624-32. PubMed ID: 16153905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel protein-engineered hepatocyte growth factor analog released via a shear-thinning injectable hydrogel enhances post-infarction ventricular function.
    Steele AN; Cai L; Truong VN; Edwards BB; Goldstone AB; Eskandari A; Mitchell AC; Marquardt LM; Foster AA; Cochran JR; Heilshorn SC; Woo YJ
    Biotechnol Bioeng; 2017 Oct; 114(10):2379-2389. PubMed ID: 28574594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.